Literature DB >> 21270116

FXR activation inhibits inflammation and preserves the intestinal barrier in IBD.

Manon E Wildenberg1, Gijs R van den Brink.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21270116     DOI： 10.1136/gut.2010.233304

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  14 in total

Review 1.  The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel disease.

Authors:  Maja Stojancevic; Karmen Stankov; Momir Mikov
Journal:  Can J Gastroenterol       Date:  2012-09       Impact factor: 3.522

Review 2.  Role of farnesoid X receptor in inflammation and resolution.

Authors:  Firdose Begum Shaik; Durbaka V R Prasad; Venkata Ramireddy Narala
Journal:  Inflamm Res       Date:  2014-11-07       Impact factor: 4.575

Review 3.  Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology.

Authors:  Claudia D Fuchs; Michael Trauner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-02-14       Impact factor: 73.082

Review 4.  Liver macrophages and inflammation in physiology and physiopathology of non-alcoholic fatty liver disease.

Authors:  Ronan Thibaut; Matthew C Gage; Inès Pineda-Torra; Gwladys Chabrier; Nicolas Venteclef; Fawaz Alzaid
Journal:  FEBS J       Date:  2021-05-02       Impact factor: 5.622

5.  Bacterial bile metabolising gene abundance in Crohn's, ulcerative colitis and type 2 diabetes metagenomes.

Authors:  Alain Labbé; Jorge G Ganopolsky; Christopher J Martoni; Satya Prakash; Mitchell L Jones
Journal:  PLoS One       Date:  2014-12-17       Impact factor: 3.240

6.  HuangQin Decoction Attenuates CPT-11-Induced Gastrointestinal Toxicity by Regulating Bile Acids Metabolism Homeostasis.

Authors:  Xu Wang; Dong-Ni Cui; Xiao-Min Dai; Jing Wang; Wei Zhang; Zun-Jian Zhang; Feng-Guo Xu
Journal:  Front Pharmacol       Date:  2017-03-30       Impact factor: 5.810

Review 7.  Bile Acids Activated Receptors in Inflammatory Bowel Disease.

Authors:  Michele Biagioli; Silvia Marchianò; Adriana Carino; Cristina Di Giorgio; Luca Santucci; Eleonora Distrutti; Stefano Fiorucci
Journal:  Cells       Date:  2021-05-21       Impact factor: 6.600

8.  Association of genetic variation in the NR1H4 gene, encoding the nuclear bile acid receptor FXR, with inflammatory bowel disease.

Authors:  Ragam Attinkara; Jessica Mwinyi; Kaspar Truninger; Jaroslaw Regula; Pawel Gaj; Gerhard Rogler; Gerd A Kullak-Ublick; Jyrki J Eloranta
Journal:  BMC Res Notes       Date:  2012-08-28

9.  The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation.

Authors:  Barbara Renga; Andrea Mencarelli; Sabrina Cipriani; Claudio D'Amore; Adriana Carino; Angela Bruno; Daniela Francisci; Angela Zampella; Eleonora Distrutti; Stefano Fiorucci
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

10.  Activated farnesoid X receptor attenuates apoptosis and liver injury in autoimmune hepatitis.

Authors:  Fan Lian; Yu Wang; Youjun Xiao; Xiwen Wu; Hanshi Xu; Liuqin Liang; Xiuyan Yang
Journal:  Mol Med Rep       Date:  2015-07-31       Impact factor: 2.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.